Urjit Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Satisfied Charges ₹ 5.74 M
- Revenue Growth 44.43%
- Profit Growth 105.91%
- Ebitda 9.72%
- Net Worth 1.06%
- Total Assets 46.07%
About Urjit Biotech
Urjit Biotech Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2006 and has a history of 18 years and six months. Its registered office is in Sangli, Maharashtra, India.
The Corporate was formerly known as Urjit-Passco Solid Waste Management Systems Private Limited. The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹5.74 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwini Gore and Chetan Gore serve as directors at the Company.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2006PTC128855
-
Company No.
128855
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Aug 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Urjit Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Gore
|
Director | 26-Jul-2016 | Current |
|
Chetan Gore
|
Director | 07-Aug-2006 | Current |
Financial Performance of Urjit Biotech.
Urjit Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.43% increase. The company also saw a substantial improvement in profitability, with a 105.91% increase in profit. The company's net worth moved up by a moderate rise of 1.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Urjit Biotech?
In 2020, Urjit Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹5.74 M
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2021 | Others | ₹1.00 Cr | Open |
| 05 Oct 2020 | Others | ₹3.00 M | Satisfied |
| 14 Feb 2019 | Others | ₹0.75 M | Satisfied |
| 12 Dec 2018 | Others | ₹1.24 M | Satisfied |
| 10 Dec 2018 | Others | ₹0.75 M | Satisfied |
How Many Employees Work at Urjit Biotech?
Unlock and access historical data on people associated with Urjit Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urjit Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urjit Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
